JPRN-jRCTs011180031进行中（未招募）3 期
Prednisolone and cyclosporine combination therapy for early onset of Vogt-Koyanagi-Harada disease - PSL/CYA therapy for early onset of VKH disease
amba Kenichi0 个研究点目标入组 120 人开始时间: 2019年3月25日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 70age old（—）
- 性别
- All
入选标准
- •1. Early onset of Vogt-Koyanagi-Harada (VKH) disease with all of a)-d)
- •a) within 4 weeks from onset
- •b) anterior chamber cells less than or equal to 2+
- •c) with typical serous retinal detachment (SRD)
- •d) without sunset glow fundus
- •2. Complete or Incomplete type of VKH disease
- •3. Presence of cerebrospinal fluid pleocytosis or meningeal irritating sign except for headache
- •4. Able to receive treatment within 4 weeks from onset
- •5. Written informed consent
排除标准
- •1. Renal dysfunction
- •2. Receiving immunosuppressant or corticosteroid therapy
- •3. State of immunosuppression
- •4. Pregnant, unwilling to practice contraception during the study, or lactating female
- •5. Malignant tumor
- •6. Intraocular surgery (except for cataract surgery) or glaucoma surgery in the past or future
研究者
相似试验
未知
不适用
A combination of cyclosporine and prednisolone and a combination of methylprednisolone, cyclosporine and prednisolone for steroid-resistant nephrotic syndrome in children: A randomized controlled studySteroid-resistant nephrotic syndrome in childrenJPRN-C000000007Japanese Study Group of Kidney Disease in Children90
已完成
不适用
The combination therapy of prednisolone and cyclosporine for initial onset of Vogt-Koyanagi-Harada disease.Vogt-Koyanagi-Harada diseaseJPRN-UMIN000017093niversity of Tokyo Graduate School of Medicine120
已完成
不适用
The combination therapy of prednisolone and cyclosporine for initial onset of Vogt-Koyanagi- Harada disease.Vogt-Koyanagi- Harada diseaseJPRN-UMIN000013373Hokkaido University Graduate School of Medicine120
招募中
不适用
The combination therapy of prednisolone and cyclosporine for initial onset of Vogt-Koyanagi-Harada disease.Vogt-Koyanagi-Harada diseaseJPRN-UMIN000014041Yamaguchi University Hospital120
已完成
不适用
Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06)Steroid-sensitive nephrotic syndromeJPRN-C000000379Japanese Study Group of Renal Disease in Children(JSRDC)50